Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice:: Role of CRF receptor subtypes 1 and 2

被引:157
作者
Martínez, V
Wang, LX
Rivier, JE
Vale, W
Taché, Y
机构
[1] Univ Calif Los Angeles, Dept Med, Div Digest Dis, VA Greater Los Angeles Healthcare Syst,CURE,DDRC, Los Angeles, CA 90073 USA
[2] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90073 USA
[3] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1124/jpet.301.2.611
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peripheral CRF inhibits gastric emptying and stimulates colonic motor function in rats. We investigated the role of CRF1 and CRF2 receptors in i.p. CRF-induced alterations of gut transit in conscious mice using selective CRF1 and CRF2 ligands injected i.p. Gastric emptying 2 h after ingestion of a solid chow meal and colonic transit (time to expel a bead inserted into the distal colon) were determined simultaneously. Rat/human (r/h)CRF, which has CRF1 > CRF2 binding affinity, decreased distal colonic transit time at lower doses (6-12 mug/kg) than those inhibiting gastric emptying (20-60 mug/kg). Ovine CRF, a preferential CRF1 receptor agonist (6-60 mug/kg), reduced significantly the colonic transit time without altering gastric emptying, whereas the selective CRF2 receptor agonists mouse urocortin II (20-60 mug/kg) and urocortin III (120 mug/kg) inhibited significantly gastric emptying without modifying colonic transit. The CRF1/CRF2 receptor antagonist, astressin (30-120 mug/kg), dose dependently prevented r/hCRF (20 mug/kg)-induced inhibition of gastric emptying and reduction of colonic transit time. The selective CRF1 receptor antagonists, NBI-27914 (C18H20Cl4N4C7H8O3S) and CP-154,526 (butyl-[2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo[2,3-d] pyrimidin-4-yl]ethylamine) (5-30 mg/kg), dose dependently blocked r/hCRF action on the colon without influencing the gastric response, whereas the CRF2 receptor antagonist, antisauvagine-30 (30-100 mug/kg), dose dependently abolished r/hCRF-induced delayed gastric emptying and had no effect on colonic response. These data show that i.p. r/hCRF-induced opposite actions on upper and lower gut transit in conscious mice are mediated by different CRF receptor subtypes: the activation of CRF1 receptors stimulates colonic propulsive activity, whereas activation of CRF2 receptors inhibits gastric emptying.
引用
收藏
页码:611 / 617
页数:7
相关论文
共 44 条
  • [31] Radulovic J, 1999, J NEUROSCI, V19, P5016
  • [32] RAYBOULD HE, 1990, J GASTROINTEST MOTIL, V2, P265
  • [33] Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors
    Reyes, TM
    Lewis, K
    Perrin, MH
    Kunitake, KS
    Vaughan, J
    Arias, CA
    Hogenesch, JB
    Gulyas, J
    Rivier, J
    Vale, WW
    Sawchenko, PE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) : 2843 - 2848
  • [34] CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors
    Schulz, DW
    Mansbach, RS
    Sprouse, J
    Braselton, JP
    Collins, J
    Corman, M
    Dunaiskis, A
    Faraci, S
    Schmidt, AW
    Seeger, T
    Seymour, P
    Tingley, FD
    Winston, EN
    Chen, YL
    Heym, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (19) : 10477 - 10482
  • [35] GASTROINTESTINAL MOTOR EFFECTS OF CORTICOTROPIN-RELEASING FACTOR IN MICE
    SHELDON, RJ
    JIANG, Q
    PORRECA, F
    FISHER, LA
    [J]. REGULATORY PEPTIDES, 1990, 28 (02) : 137 - 151
  • [36] CENTRAL-NERVOUS-SYSTEM ACTION OF CORTICOTROPIN-RELEASING FACTOR TO INHIBIT GASTRIC-EMPTYING IN RATS
    TACHE, Y
    MAEDAHAGIWARA, M
    TURKELSON, CM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 253 (02): : G241 - G245
  • [37] Turnbull AV, 1997, P SOC EXP BIOL MED, V215, P1
  • [38] CHARACTERIZATION OF A 41-RESIDUE OVINE HYPOTHALAMIC PEPTIDE THAT STIMULATES SECRETION OF CORTICOTROPIN AND BETA-ENDORPHIN
    VALE, W
    SPIESS, J
    RIVIER, C
    RIVIER, J
    [J]. SCIENCE, 1981, 213 (4514) : 1394 - 1397
  • [39] Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO
  • [40] 2-U